Zhejiang Cheng Yi Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Zhejiang Cheng Yi Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.69 Million ≈ $8.15 Million USD) by net assets (CN¥1.33 Billion ≈ $194.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
Cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 603811 stock price and chart for real-time trading data and today's change.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Cheng Yi Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangxi Huawu Brake Co Ltd
SHE:300095
|
0.038x |
|
Kedge Construction Co Ltd
TW:2546
|
-0.134x |
|
FONDUL PRO.GDR REGS LN-85
F:FP4G
|
N/A |
|
Korea New Network Co. Ltd
KQ:058400
|
0.023x |
|
Chengdu Lihang Technology Co.Ltd.
SHG:603261
|
N/A |
|
CHC Resources Corp
TW:9930
|
0.081x |
|
Tejon Ranch Co
NYSE:TRC
|
0.003x |
|
Kaiser China Holding Co Ltd
SHE:002425
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. Review Zhejiang Cheng Yi Pharmaceutical Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.40 Billion ≈ $204.54 Million |
CN¥280.39 Million ≈ $41.03 Million |
0.201x | +23.36% |
| 2024-12-31 | CN¥1.27 Billion ≈ $185.12 Million |
CN¥205.72 Million ≈ $30.10 Million |
0.163x | -0.10% |
| 2023-12-31 | CN¥1.20 Billion ≈ $175.10 Million |
CN¥194.78 Million ≈ $28.50 Million |
0.163x | +7.02% |
| 2022-12-31 | CN¥1.09 Billion ≈ $159.64 Million |
CN¥165.94 Million ≈ $24.28 Million |
0.152x | +5.89% |
| 2021-12-31 | CN¥998.88 Million ≈ $146.17 Million |
CN¥143.49 Million ≈ $21.00 Million |
0.144x | -28.41% |
| 2020-12-31 | CN¥886.09 Million ≈ $129.66 Million |
CN¥177.81 Million ≈ $26.02 Million |
0.201x | -14.76% |
| 2019-12-31 | CN¥768.96 Million ≈ $112.52 Million |
CN¥181.01 Million ≈ $26.49 Million |
0.235x | +18.06% |
| 2018-12-31 | CN¥673.54 Million ≈ $98.56 Million |
CN¥134.30 Million ≈ $19.65 Million |
0.199x | +79.10% |
| 2017-12-31 | CN¥599.57 Million ≈ $87.74 Million |
CN¥66.75 Million ≈ $9.77 Million |
0.111x | -67.19% |
| 2016-12-31 | CN¥280.17 Million ≈ $41.00 Million |
CN¥95.08 Million ≈ $13.91 Million |
0.339x | +7.65% |
| 2015-12-31 | CN¥259.92 Million ≈ $38.03 Million |
CN¥81.94 Million ≈ $11.99 Million |
0.315x | -7.44% |
| 2014-12-31 | CN¥246.95 Million ≈ $36.14 Million |
CN¥84.11 Million ≈ $12.31 Million |
0.341x | +42.35% |
| 2013-12-31 | CN¥201.40 Million ≈ $29.47 Million |
CN¥48.19 Million ≈ $7.05 Million |
0.239x | +12.28% |
| 2012-12-31 | CN¥178.13 Million ≈ $26.07 Million |
CN¥37.96 Million ≈ $5.55 Million |
0.213x | +117.73% |
| 2011-12-31 | CN¥102.60 Million ≈ $15.01 Million |
CN¥10.04 Million ≈ $1.47 Million |
0.098x | -- |
About Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, cap… Read more